PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy
β Scribed by William H. Theodore; Richard E. Carson; Paul Andreasen; Allan Zametkin; Ron Blasberg; Deborah B. Leiderman; Kenner Rice; Amy Newman; Michael Channing; Bonnie Dunn; Norman Simpson; Peter Herscovitch
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 947 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0920-1211
No coin nor oath required. For personal study only.
β¦ Synopsis
We used [18F]cyclofoxy (CF), a potent opiate antagonist with affinity for mu and kappa receptors, and the Scanditronix PC1024-7B PET scanner to study 14 patients with complex partial seizures (CPS), and 14 normal controls. Epileptic foci were localized by prolonged EEG-video monitoring. EEG was recorded continuously during each scan. Immediately before CF administration, [15O]labeled water was used to measure cerebral blood flow, and showed hypoperfusion ipsilateral to the EEG focus. Blood samples (corrected for radiolabeled metabolites) and tissue time-activity data were acquired over 90 min following bolus CF injection. Anatomic regions were outlined directly on the PET images. A kinetic model was used to derive the total volume of distribution (Vt) in each brain region. Specific binding (Vs) was determined by substracting non-specific binding (Vt) measured in a receptor-poor brain region (occipital cortex). Regions with high Vs included mesial temporal lobes, thalamus, basal ganglia, and frontal cortex. Individual patients appeared to have higher binding in temporal lobe ipsilateral to the EEG focus, but there was no asymmetry for the patients as a group in mean Vt or Vs in anterior mesial, posterior mesial, anterior lateral, posterior lateral temporal cortex, thalamus, basal ganglia, or, for Vt, in regions of low specific binding: occipital lobe, parietal lobe, cerebellum.
π SIMILAR VOLUMES
## Abstract [^18^F]SPAβRQ is an effective radioligand for imaging brain neurokinin typeβ1 (NK~1~) receptors in clinical research and drug discovery with positron emission tomography. For the automated regular production of [^18^F]SPAβRQ for clinical use in the USA under an IND we chose to use a mod
[(18)F]Fallypride is a highly selective, high-affinity dopamine D-2 receptor ligand. The high affinity, K(D) = 30 pM, makes it a suitable candidate for visualizing both striatal and extrastriatal binding in the brain. In this work, dynamic PET studies of two macaque monkeys were acquired along with